Evidence map›Paper›PMID 35682281›Full record

ArticleInternational journal of environmental research and public health2022

The Efficacy of Animal-Assisted Therapy in Patients with Dual Diagnosis: Schizophrenia and Addiction.

Miguel Monfort, Ana Benito, Gonzalo Haro, Alejandro Fuertes-Saiz, Monserrat Cañabate, Abel Baquero

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Miguel MonfortTXP Research Group, Universidad Cardenal Herrera-CEU, CEU Universities, 12006 Castellón de la Plana, Spain.
Ana BenitoTXP Research Group, Universidad Cardenal Herrera-CEU, CEU Universities, 12006 Castellón de la Plana, Spain.ORCID 0000-0002-0785-3570
Gonzalo HaroTXP Research Group, Universidad Cardenal Herrera-CEU, CEU Universities, 12006 Castellón de la Plana, Spain.ORCID 0000-0002-1299-9611
Alejandro Fuertes-SaizTXP Research Group, Universidad Cardenal Herrera-CEU, CEU Universities, 12006 Castellón de la Plana, Spain.ORCID 0000-0001-5410-8701
Monserrat CañabateTXP Research Group, Universidad Cardenal Herrera-CEU, CEU Universities, 12006 Castellón de la Plana, Spain.
Abel BaqueroTXP Research Group, Universidad Cardenal Herrera-CEU, CEU Universities, 12006 Castellón de la Plana, Spain.
Universidad Cardenal Herrera CEU · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of the study was to evaluate the efficacy of an animal-assisted-therapy (AAT) program in patients diagnosed with schizophrenia-spectrum disorders and substance-use disorders in residential treatment in order to intervene in the remission of negative and positive symptoms and improve quality of life and adherence to treatment, favouring the clinical stabilization of patients who participate in the AAT program, within the context of a mental-illness-treatment device. This was a quasi-experimental prospective study with intersubject and intrasubject factors. The sample comprised 36 patients (21 in the experimental group and 15 in the control group) who were evaluated at three time points (in the 3rd, 6th, and 10th sessions). The program lasted 3 months and consisted of 10 sessions that were implemented once a week, with a maximum participation of 10 patients per group. The participants were evaluated with the Positive and Negative Syndrome Scale (PANSS) for schizophrenia and the Life Skills Profile-20 (LSP-20) questionnaire. We observed a decrease in the positive symptoms of psychosis (F: 27.80, p = 0.001) and an improvement in functionality (F: 26.70, p < 0.001) as the sessions progressed. On the basis of these results, we concluded that AAT seems to be valid as a coadjuvant therapy as part of the rehabilitation processes of patients diagnosed with schizophrenia and addiction-spectrum disorders (dual diagnosis).

Indexed as

Animal Assisted TherapyPsychotic DisordersSchizophreniaSubstance-Related DisordersAnimalsHumansProspective StudiesQuality of Lifeaddictionanimal-assisted therapydaily living skillsdual diagnosisresidential treatment

Identifiers

PMID35682281
PMCPMC9180053
OpenAlexW4281956335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.